February, 20 2025, 04:44pm EDT

For Immediate Release
Contact:
Elizabeth Heyd, eheyd@nrdc.org; David Sligh, david@wildvirginia.org; Dan Radmacher, dan@appvoices.org; Andy Li, andy.li@sierraclub.org
DC Circuit Hears Arguments on FERC's MVP Southgate Pipeline Approval
Today, the U.S. Court of Appeals for the D.C. Circuit heard oral argument challenging the Federal Energy Regulatory Commission’s (FERC) decision to extend the construction deadline for the Mountain Valley Pipeline (MVP) Southgate project through Virginia and North Carolina. Environmental petitioners contend that FERC’s decision disregarded the pipeline developer’s admission that it actually intends to construct a significantly different “redesigned” project in lieu of the FERC-approved project, and that FERC failed to uphold its legal obligation to conduct a thorough environmental and public interest review. As a result of the extension order, MVP maintains the power to take private property through eminent domain even though its new project has not been found to serve the public interest.
Appalachian Mountain Advocates argued the case on behalf of the environmental petitioners Appalachian Voices, Blue Ridge Environmental Defense League (BREDL), Center for Biological Diversity, Chesapeake Climate Action Network, Haw River Assembly, NRDC (Natural Resources Defense Council), Sierra Club and Wild Virginia. Mere days after FERC granted an extension for the original project’s certificate in December 2023, MVP Southgate developers announced a major project overhaul, including increasing the pipeline’s gas capacity by nearly 50 percent and altering the pipeline route. Despite these drastic changes, FERC extended the project’s certificate without an updated environmental or public interest review. Since then, MVP has applied for an amendment for the Southgate project, continuing its attempts to circumvent a meaningful approval process. Conservation groups are calling for FERC to abrogate the extended certificate that authorizes MVP to exercise the power of eminent domain, and to require MVP to conduct a new review and approval process to fully evaluate the new project’s impacts.
The Southgate project has faced overwhelming opposition from local communities, environmental organizations, and state officials. More than 39,000 public comments were submitted urging FERC to deny the extension, citing environmental risks, lack of need, and concerns over eminent domain, including from then-North Carolina Gov. Roy Cooper and dozens of state and federal lawmakers. North Carolina’s Department of Environmental Quality has twice denied MVP critical water quality permits, and concerns over the project’s impact on environmental justice communities remain unresolved.
Critics point out that the project would lock power company customers into decades of paying for fossil fuels while endangering sensitive ecosystems and vulnerable communities along its route.
“FERC’s approval of the MVP Southgate project is an example of another dangerous and unnecessary fossil fuel project getting a pass,” said Caroline Reiser, Senior Staff Attorney, Climate & Energy at NRDC. “The further expansion of fossil fuel infrastructure threatens public health, clean water, and the climate.”
“The damage to our waters and our communities caused by the Mountain Valley Pipeline are an ugly predictor of the destruction the Southgate project will cause,” said David Sligh, Wild Virginia’s Conservation Director. “It is inexcusable for FERC to ignore that evidence and allow the same kind of costs and pain to be imposed on the people and environments along Southgate’s proposed path.”
"Although this project shares many of the same impacts to critical, high-quality watersheds like the Dan River that are vital to tourism, drinking water and industry in the region, the significant shift of Southgate to supply gas to Duke Energy's new, proposed gas plants is a major departure from the impacts studied by FERC in the original approval,” said Ridge Graham, North Carolina Program Manager for Appalachian Voices. “Retaining the same outdated and inadequate certificate without reevaluation is not acceptable."
"FERC cannot allow the burden of Mountain Valley Pipeline’s unneeded and dangerous Southgate extension to be pushed onto residents already bearing the brunt of the climate crisis,” said Caroline Hansley, Campaign Organizing Strategist with Sierra Club. “MVP should not be allowed to use a FERC certificate granted years ago for a dramatically different project to take private property for its new project, which would carry nearly 50 percent more methane gas. Virginia and North Carolina communities have made it clear for seven years – they don’t need or want Southgate. It’s time for FERC to listen.”
“We suspect that Southgate is another link in a chain of pipelines designed to allow for the large-scale exploitation of American fracked gas for overseas export, and that’s why we plan to use every lawful tool at our disposal to fight it to the finish.” said Perrin de Jong, senior attorney for the Center for Biological Diversity. “The cost to both Americans and American wildlife would be heavy, while the profits of this diabolical scheme would flow to elite corporate executives in their plush penthouses.”
NRDC works to safeguard the earth--its people, its plants and animals, and the natural systems on which all life depends. We combine the power of more than three million members and online activists with the expertise of some 700 scientists, lawyers, and policy advocates across the globe to ensure the rights of all people to the air, the water, and the wild.
(212) 727-2700LATEST NEWS
Trump Taps 'Manifestly Unqualified' Peter Thiel Protégé as Acting CDC Director After RFK's Purge
A health researcher for Public Citizen said Trump's interim CDC director has "no medical or public health background and extremist libertarian views."
Aug 29, 2025
After pushing out his own handpicked Centers for Disease Control and Prevention (CDC) director, infectious disease expert Susan Monarez, fueling a wave of outraged resignations this week, US President Donald Trump has appointed a loyal acolyte to replace her at Health and Human Services Secretary Robert F. Kennedy Jr.'s side.
On Thursday, the president tapped one of RFK's top aides as interim CDC director: biotech investor Jim O'Neill, a man with no medical experience but extensive experience profiting from healthcare while working at billionaire GOP megadonor Peter Thiel's venture capital firm, Mithril Capital.
Unlike his predecessor, whose ouster came as she tried to push back against RFK's anti-vaccine agenda, O'Neill fits snugly into the secretary's efforts to restrict access to the Covid-19 vaccine, and potentially ban it outright, as the Daily Beast reported earlier this week.
"A tech investor with no medical or public health background and extremist libertarian views, Jim O'Neill was unfit for the number two position at HHS and manifestly unqualified to lead the CDC," said Dr. Robert Steinbrook, director of Public Citizen's health research group, on Friday.
Just as Kennedy did during his confirmation hearings, O'Neill insisted he was "pro-vaccine," noting that he was "an adviser to a vaccine company." However, this is belied by his record on the subject.
He has championed unproven cures like ivermectin, hydroxychloroquine, and vitamin D supplements to protect against Covid-19, and has accused the CDC under the administration of former President Joe Biden of downplaying the vaccine's dangers while railing against mandates.
O'Neill has also praised Kennedy's response to the measles outbreak that swept across the US earlier this year, during which the secretary downplayed the severity and cast unfounded doubt on the effectiveness and safety of the measles vaccine that had virtually eradicated the disease before vaccination rates began to decline.
"Unlike Susan Monarez," Steinbrook said, "O'Neill is likely to rubber-stamp dangerous vaccine recommendations from HHS Secretary Kennedy's handpicked appointees to the Advisory Committee on Immunization Practices and obey orders to fire CDC public health experts with scientific integrity."
O'Neill melds medical crankery with a Thielite strain of anarcho-libertarianism. He has served on the board of the Seasteading Institute, an organization founded by Patri Friedman, the grandson of the right-wing economist Milton Friedman, who advocates for corporations like Apple and Google to form their own floating cities at sea, which would be governed as corporate "dictatorships" free from the constraints of democratic governance.
That anti-government ethos extends to his views on the healthcare system, which O'Neill says is flawed not because of the rampant profiteering of the private companies that run it, but because it is supposedly not "free market" enough.
In 2014, he advocated for the Food and Drug Administration (FDA) to begin approving drugs for the market without conducting clinical trials to determine their effectiveness. "Let people start using them, at their own risk," he argued, "Let's prove efficacy after they've been legalized."
He has also argued for the government to allow people to sell their own internal organs. This process often results in deteriorating health for the disproportionately poor people who partake.
While working at HHS under the administration of former President George W. Bush, O'Neill also opposed the FDA regulation of companies that use algorithms to perform laboratory tests.
At the time, he was focused on DNA testing products like 23andMe, but a report from the consumer watchdog group Public Citizen says that "a decade after he made this remark, it's clear how dangerous such a concept is," noting that "with the development and proliferation of artificial intelligence, algorithms are omnipresent in the practice of medicine, including in diagnostic tools, medical devices, AI assistants to doctors, and personalized medicine."
In addition to Thiel's ideology, he reportedly brings several conflicts of interest to the CDC director job from his time working at Thiel's venture capital firm.
Accountable.US reported Friday that O'Neill "took money from, helped incubate, or was otherwise linked to at least eight medical industry startups with direct business before the department he could help run."
These include firms he advised, like the pharmaceutical company ADvantage Therapeutics or the National Institutes of Health grantee Rational Vaccines, which manufactures herpes drugs.
It also includes four companies seeded by his Thiel-affiliated venture capital firm Breakout Labs, some of which have received government funding or have products awaiting FDA approval.
Though O'Neill agreed to divest from some of these companies and abstain from involvement in decision-making with them as part of his ethics agreement, the report notes that "he did not promise to abstain from decisions involving these companies for the duration of his term, or to abstain from doing business with them after departing HHS."
"O'Neill would be in a prime position to ensure favorable outcomes for several medical industry startups he's been financially linked to that have direct business before HHS and the CDC," said Accountable.US executive director Tony Carrk. "How can American patients be sure that proper vetting of these companies would take place on O'Neill's watch and that public health will be a higher priority over the profits of his former clients?"
Though Steinbrook describes O'Neill as "manifestly unqualified" for the position, he said, "No credible public health authority is likely to work for Kennedy, who is dictating the agency's decisions based on whim, not science."
"The only path forward," Steinbrook said, "is for Kennedy to go, which Congress, professional organizations, medical journals, and the public should demand."
Keep ReadingShow Less
'AI Death Panels': Trump Pilot Program Seeks to Bring 'Very Worst' For-Profit Insurance Practices to Medicare
The administration, warned two union leaders, "is inserting private AI companies, which have a giant financial stake in the denial of care, into the doctor-patient relationship."
Aug 29, 2025
Creating what critics are equating to "AI death panels" elderly Americans in need of care, the Trump administration is launching a pilot program in six states that will use artificial intelligence to determine whether Medicare recipients should qualify for certain procedures.
As reported by The New York Times on Thursday, the pilot program will hire private firms to deploy AI to make what are known as "prior authorization" decisions regarding whether Medicare should pay for certain procedures, including spinal surgeries and steroid injections. The program is set to run first in Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington.
According to the paper, the program will rely on algorithms similar to those "used by insurers have been the subject of several high-profile lawsuits, which have asserted that the technology allowed the companies to swiftly deny large batches of claims and cut patients off from care in rehabilitation facilities."
The way the program is being structured will also give AI firms big incentives to maximize the denial of claims for Medicare recipients, as the Times reported that "Medicare plans to pay them a share of the savings generated from rejections."
Abe Sutton, the director of the Center for Medicare and Medicaid Innovation, emphasized in an interview with the Times that this program would not be used to review emergency services or hospital stays.
Even so, some experts and advocates have warned that this program risks bringing the same problems experienced by people who use private insurance to Medicare.
"It's basically the same set of financial incentives that has created issues in Medicare Advantage and drawn so much scrutiny," Ohio-based surgeon Dr. Vinay Rathi, who is also an expert in Medicare payment policies, explained to the Times. "It directly puts them at odds with the clinicians."
Jathan Sadowski, a senior lecturer and research fellow in the Emerging Technologies Research Lab at Monash University, also warned about private insurance practices creeping into traditional Medicare.
"The government is hiring companies using AI to make those determinations about healthcare," he wrote on X. "This is exactly the same tactic that private insurers like UnitedHealth use to delay and deny treatment."
The reported pilot program also drew harsh reviews from the American Federation of Teachers (AFT), as president Randi Weingarten and the union's Retirees Program and Policy Council co-chair Tom Murphy issued a joint statement accusing the Trump administration of "attempting to transform Medicare into the very worst of private insurance."
"Instead of making life easier and better for older Americans, this administration is introducing extra hurdles that are burdensome to patients and often get in the way of their desperately needed treatments," they said. "And the administration is inserting private AI companies, which have a giant financial stake in the denial of care, into the doctor-patient relationship."
Keep ReadingShow Less
'Another Act of Revenge': Trump Cancels Secret Service Extended Protection for Kamala Harris
"The safety of our public officials should never be subject to erratic, vindictive political impulses," said a spokesman for California Gov. Gavin Newsom.
Aug 29, 2025
US President Donald Trump has canceled extended Secret Service protection for former Vice President Kamala Harris just as she was scheduled to go on a multi-city book tour.
CNN reported on Friday that Trump this week sent a letter to the Department of Homeland Security that simply read, "You are hereby authorized to discontinue any security-related procedures previously authorized by executive memorandum, beyond those required by law, for the following individual, effective September 1, 2025: Former Vice President Kamala D. Harris."
As CNN explained, former vice presidents are entitled by federal law to six months of Secret Service protection after leaving office.
However, former President Joe Biden late in his term signed a directive that extended Harris' protection past the standard six-month window. The reason for the extension—its existence not reported publicly until Trump moved to revoke it—has not been made clear.
Harris last year was the Democratic Party's presidential nominee after then-President Joe Biden decided against running for a second term.
As California is Harris' home state, both California Gov. Gavin Newsom and Los Angeles Mayor Karen Bass are aware of and have been discussing Harris' security situation, and CNN noted she could get added protection in the future from the Los Angeles Police Department or potentially another state agency.
In a statement given to CNN, Bass delivered a scathing denunciation of the president for revoking his former rival's Secret Service protection.
"This is another act of revenge following a long list of political retaliation in the form of firings, the revoking of security clearances and more," she said. "This puts the former Vice President in danger and I look forward to working with the Governor to make sure Vice President Harris is safe in Los Angeles."
Bob Salladay, a spokesman for Newsom, also ripped the president for his actions.
"The safety of our public officials should never be subject to erratic, vindictive political impulses," he said.
Harris is scheduled to go on tour starting next month in New York to promote her book "107 Days," which reflects on her failed 2024 presidential campaign.
Keep ReadingShow Less
Most Popular